Clean Yield Group Amgen Inc Transaction History

Clean Yield Group

  • $293 Million
  • Q4 2024

A detailed history of Clean Yield Group transactions in Amgen Inc stock. As of the latest transaction made, Clean Yield Group holds 6,008 shares of AMGN stock, worth $1.74 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
6,008
Previous 6,058 0.83%
Holding current value
$1.74 Million
Previous $1.95 Million 19.78%
% of portfolio
0.53%
Previous 0.66%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 13, 2025
SELL
$258.78 - $328.31 $12,938 - $16,415
-50 Reduced 0.83%
6,008 $1.57 Million
Q3 2024

Oct 07, 2024
SELL
$309.38 - $337.38 $224,609 - $244,937
-726 Reduced 10.7%
6,058 $1.95 Million
Q2 2024

Jul 10, 2024
SELL
$262.75 - $319.31 $68,315 - $83,020
-260 Reduced 3.69%
6,784 $2.12 Million
Q1 2024

May 29, 2024
SELL
$268.87 - $324.56 $82,005 - $98,990
-305 Reduced 4.15%
7,044 $2 Million
Q4 2023

Jan 24, 2024
SELL
$255.7 - $288.46 $30,684 - $34,615
-120 Reduced 1.61%
7,349 $2.12 Million
Q3 2023

Oct 12, 2023
SELL
$218.65 - $271.46 $115,884 - $143,873
-530 Reduced 6.63%
7,469 $2.01 Million
Q2 2023

Jul 26, 2023
SELL
$214.27 - $253.37 $135,418 - $160,129
-632 Reduced 7.32%
7,999 $1.78 Million
Q1 2023

Apr 26, 2023
SELL
$225.79 - $275.2 $470,772 - $573,792
-2,085 Reduced 19.46%
8,631 $2.09 Million
Q4 2022

Jan 31, 2023
SELL
$229.03 - $291.01 $137,647 - $174,897
-601 Reduced 5.31%
10,716 $2.81 Million
Q3 2022

Oct 31, 2022
SELL
$224.46 - $253.15 $160,488 - $181,002
-715 Reduced 5.94%
11,317 $2.55 Million
Q2 2022

Jul 18, 2022
SELL
$230.71 - $256.74 $68,059 - $75,738
-295 Reduced 2.39%
12,032 $2.93 Million
Q1 2022

Apr 25, 2022
SELL
$219.27 - $242.57 $70,166 - $77,622
-320 Reduced 2.53%
12,327 $2.98 Million
Q4 2021

Jan 24, 2022
BUY
$198.88 - $227.6 $52,902 - $60,541
266 Added 2.15%
12,647 $2.85 Million
Q3 2021

Oct 27, 2021
BUY
$212.27 - $248.7 $89,365 - $104,702
421 Added 3.52%
12,381 $2.63 Million
Q1 2021

Apr 26, 2021
SELL
$221.91 - $258.6 $125,157 - $145,850
-564 Reduced 4.5%
11,960 $2.98 Million
Q4 2020

Jan 26, 2021
SELL
$216.38 - $257.67 $21,638 - $25,767
-100 Reduced 0.79%
12,524 $2.88 Million
Q3 2020

Oct 16, 2020
SELL
$234.65 - $260.95 $43,644 - $48,536
-186 Reduced 1.45%
12,624 $3.21 Million
Q2 2020

Jul 22, 2020
SELL
$197.81 - $242.74 $200,777 - $246,381
-1,015 Reduced 7.34%
12,810 $3.02 Million
Q1 2020

Apr 20, 2020
SELL
$182.24 - $241.7 $305,069 - $404,605
-1,674 Reduced 10.8%
13,825 $2.8 Million
Q4 2019

Jan 17, 2020
SELL
$189.21 - $243.2 $338,496 - $435,084
-1,789 Reduced 10.35%
15,499 $3.74 Million
Q3 2019

Oct 23, 2019
SELL
$174.11 - $208.62 $165,056 - $197,771
-948 Reduced 5.2%
17,288 $3.35 Million
Q2 2019

Jul 22, 2019
SELL
$166.7 - $195.41 $357,404 - $418,959
-2,144 Reduced 10.52%
18,236 $3.36 Million
Q1 2019

Apr 24, 2019
SELL
$180.87 - $203.88 $5,426 - $6,116
-30 Reduced 0.15%
20,380 $3.87 Million
Q4 2018

Jan 23, 2019
SELL
$178.4 - $208.25 $101,509 - $118,494
-569 Reduced 2.71%
20,410 $3.97 Million
Q3 2018

Oct 22, 2018
SELL
$185.29 - $208.89 $78,192 - $88,151
-422 Reduced 1.97%
20,979 $4.35 Million
Q2 2018

Jul 24, 2018
BUY
$166.05 - $186.51 $80,534 - $90,457
485 Added 2.32%
21,401 $3.95 Million
Q1 2018

Apr 23, 2018
SELL
$169.43 - $198.0 $54,217 - $63,360
-320 Reduced 1.51%
20,916 $3.57 Million
Q4 2017

Jan 16, 2018
BUY
$168.79 - $188.59 $140,939 - $157,472
835 Added 4.09%
21,236 $3.69 Million
Q3 2017

Oct 11, 2017
BUY
$167.29 - $191.0 $3.41 Million - $3.9 Million
20,401
20,401 $3.8 Million

Others Institutions Holding AMGN

# of Institutions
3,083
Shares Held
401M
Call Options Held
7.57M
Put Options Held
7.16M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Clean Yield Group Portfolio

Follow Clean Yield Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clean Yield Group, based on Form 13F filings with the SEC.

News

Stay updated on Clean Yield Group with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email